Advances in Public Health / 2022 / Article / Tab 3 / Research Article
Measles-Rubella Positivity Rate and Associated Factors in Pre-Mass and Post-Mass Vaccination Periods: Analysis of Uganda Routine Surveillance Laboratory Data Table 3 Factors associated with the rubella outcome among laboratory-examined cases before and after the 2019 measles-rubella mass vaccination campaign.
Variable Precampaign season (n = 1367) Postcampaign season (n = 316) Positive Negative χ 2 valuePositive Negative χ 2 valueSex Male 157 (22.11) 553 (77.89) 0.12 0.719 14 (7.95) 162 (92.05) 1.10 0.295 Female 140 (21.31) 517 (78.69) 7 (5.00) 133 (95.00) Age UANE 4 (3.54) 109 (96.46) <0.001 0 (0.00) 50 (100) 0.058 RICE 278 (24.84) 841 (75.16) 15 (7.21) 193 (92.79) OANE 15 (11.11) 120 (88.89) 6 (10.34) 52 (89.66) Place of residence Urban 0 (0.00) 1 (100) 1.000 0 (0.00) 2 (100) 1.000 Rural 297 (21.74) 1069 (78.26) 21 (6.69) 293 (93.31) Vaccination status Not vaccinated 119 (17.68) 554 (82.32) 32.79 <0.001 3 (2.29) 128 (97.71) 0.001 1 dose 140 (28.17) 357 (71.83) 11 (14.29) 66 (85.71) 2+ doses 23 (34.33) 44 (65.67) 1 (1.67) 59 (98.33) Unknown 15 (11.54) 115 (88.46) 6 (12.50) 42 (87.50) Vitamin A doses 1 dose 83 (22.99) 278 (77.01) 4.85 0.089 9 (13.24) 59 (86.76) 6.60 0.037 2+ doses 116 (24.12) 365 (75.88) 7 (6.09) 108 (93.91) Zero/unknown 98 (18.67) 427 (81.33) 5 (3.76) 128 (96.24) Specimen condition Good 296 (21.75) 1065 (78.25) 1.000 21 (6.65) 295 (93.35) Bad 1 (20.00) 4 (80.00) 0 (0.00) 0 (0.00)
Fisher’s exact test;
not applicable.